Xtant Medical Holdings, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2016; Reiterates Earnings Guidance for the Fiscal 2017
January 11, 2017 at 07:50 pm IST
Share
Xtant Medical Holdings, Inc. provided earnings guidance for the fourth quarter and full year of 2016. For the fourth quarter of 2016, revenue is estimated to be at least $24.5 million which represents 10.0% year on year growth as compared to revenues of $22.3 million reported in the fourth quarter of 2015. Adjusted EBITDA is estimated to be at least $1.25 million versus a loss of $350,000 in the fourth quarter of 2015.
Full year 2016 revenue is estimated to be at least $90.0 million which represents 4.1% year on year growth as compared to pro-forma revenue of $86.5 million for the full year 2015. Adjusted EBITDA is estimated to be at least $2.2 million versus a pro forma loss of $33,000 for the full year 2015.
The company reiterated 2017 revenue guidance of between $98 million and $102 million and adjusted EBITDA guidance of between $7.7 million and $9.2 million.
Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and its line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical Products, Thoracolumbar Products, Sacroiliac Joint Products, Interbody Products and Interlaminar Stabilization Products.
XTANT MEDICAL HOLDINGS, INC. 
